Nebula Biotechnology Co., Ltd..

+86-15801534258
info@nebulabio.cn
Product Name NebuSelect™ Recombinant Human TNFRSF12A/TWEAKR, hFc-tag
Catalog Number NBL-241999
Alias/Synonyms TNFRSF12A/TWEAKR; FGF-inducible 14; Fgfrp2; TNFRSF12A; FN14; CD266; TWEAKR
Appearance see COA
Molecule Weight Glu28-Per80
CAS N/A
Solubility Water Soluble
Storage Short term 4℃; Long term -20℃.
Shelf Life 2 years
Additional info 1 Q9NP84-1
Additional info 2
Catalog Numbe Size Price Inventory Level  
NBL-241999-100ug 100ug Inquire Inquire
NBL-241999-1mg 1mg Inquire Inquire
NBL-241999-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human TNFRSF12A/TWEAKR, hFc-tag


Catalog#:

NBL-241999


Description:

NebuSelect™ Recombinant Human TNFRSF12A/TWEAKR, hFc-tag(Cat#NBL-241999) is expressed in HEK293 with hFc tag at the N-Terminus.It contains Glu28-Per80.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 32.9 kDa. Due to glycosylation, the protein migrates to 38-45 kDa based on Bis-Tris PAGE result.


Target Name:

TNFRSF12A/TWEAKR; FGF-inducible 14; Fgfrp2; TNFRSF12A; FN14; CD266; TWEAKR


Target Information:

Thyroid cancer (TC) is the most well-known endocrine neoplasia as well as a common malignant tumor in the head and neck.TNFRSF12A expression may be a potential useful prognostic molecular biomarker of bad survival in thyroid cancer, in addition, PPAR signaling pathway, insulin signaling pathway, mTOR signaling pathway may be the key pathway controlled by TNFRSF12A in thyroid cancer. Further experimental ought to be performed to demonstrate the biologic effect of TNFRSF12A.


Amino Acid Sequence: 

Glu28-Per80


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

Top-selling Items